Skip to main content
. 2017 Feb 21;116(7):912–922. doi: 10.1038/bjc.2017.39

Figure 3.

Figure 3

Cdk5 inhibition reduces cancer cell motility.(A) FCS-induced migration of non-targeting (nt) or Cdk5 shRNA-transduced T24 cells is shown (mean±s.e.m., *P<0.001, n=3). (B) FCS-induced invasion of T24 cells transduced with non-targeting (nt) or Cdk5 shRNA is shown (mean±s.e.m., *P<0.001, n=3). (C) FCS-induced migration of T24 cells with/without treatment with roscovitine is shown (mean±s.e.m., *P<0.001, n=3).